Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Velcade

Approved

STANDARD

Velcade

Pierre Fabre Medicament Production🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 05d9cbe97d3c6d21
Company: Pierre Fabre Medicament Production
Type: Standard

Approval Details

Approval Id: 05d9cbe97d3c6d21
Drug Approval Philippines Name: Velcade
Product Name: Velcade
Registration Number: DR-XY39166
Brand Name: Velcade
Generic Name: Bortezomib
Dosage Form: Powder For Injection (IV/SC)
Dosage Strength: 3.5 mg/vial
Manufacturer: Pierre Fabre Medicament Production
Importer: Johnson & Johnson (Philippines), Inc.
Distributor: Zuellig Pharma Corporation
Company Detail Path: /organization/pierre-fabre-medicament-production
Issuance Date: 11 June 2021
Expiry Date: 11 March 2026
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

05d9cbe97d3c6d21

Type

Standard

Back to Philippines FDA Approvals

Velcade - Philippines FDA Drug Approval Details